Anthropic's Fable 5 Bets on Safety. Researchers Say It's Gone Too Far.
Anthropic released Claude Fable 5 to the public on Wednesday — a Mythos-class model with strict guardrails that block cybersecurity and biology queries — as the AI startup positions its safety-first brand for a confidential IPO alongside OpenAI and SpaceX.

Anthropic released Claude Fable 5 to the public on Wednesday — a Mythos-class model priced at $10 per million input tokens and outfitted with guardrails so aggressive that roughly 5 per cent of all user sessions trigger a fallback to the older, less capable Claude Opus 4.8. The launch is the company’s most substantial product milestone since its confidential IPO filing earlier this month, and it lands squarely at the intersection of two accelerating forces: the three-way AI public-offering race with OpenAI and SpaceX, and a deepening dispute over whether safety-first AI can still be useful AI.
The guardrails, by design
Fable 5 is the first broadly available model from Anthropic to carry the Mythos designation — the company’s label for frontier-level reasoning capability previously reserved for a preview programme limited to trusted partners. But the mass-market version arrives with a conspicuous asterisk. The model refuses to engage with queries touching cybersecurity, biology, or chemistry. Not only attack vectors or bio-weapon recipes: even reading a security blog post, performing a routine code review, or answering a high-school biology question gets caught in the net.

Anthropic has framed these restrictions as a necessary layer of caution for a model it describes as powerful enough to be dangerous if mishandled. The company’s safety team — the insider vantage in this debate — argues that conservative classifiers are the only reliable backstop when a model’s underlying capabilities outpace the industry’s ability to forecast misuse. In a statement accompanying the launch, Anthropic said it had identified categories of query where the risk of downstream harm outweighed the benefit of general availability, and built the guardrails accordingly.
But the execution has been blunt. According to reporting by Ars Technica, the filtering is largely keyword-based: anything in the lexical neighbourhood of “cybersecurity” triggers a downgrade to Opus 4.8, and in many cases an outright refusal. The classifiers do not appear to distinguish between a penetration tester writing a report and a bad actor probing for exploits. Both get the same locked door.
Fable rejects any request that could be tangentially cyber related. Even innocuous tasks like reading a blog post.
— Valentina ‘Chompie’ Palmiotti, security researcher
The researcher backlash
The response from the cybersecurity research community has been swift and pointed. Valentina “Chompie” Palmiotti, a prominent security researcher, told TechCrunch that Fable 5 blocked even trivial requests — reading a publicly available blog post, summarising a conference talk, performing a routine code review. Matt Suiche, another researcher who tested the model, described a system that conflates secure coding practices with offensive cybersecurity work.
If you ask it to write secure code, it assumes it is cybersecurity related work instead of software engineering best practices, and you get downgraded.
— Matt Suiche, security researcher
Suiche told TechCrunch the filtering “seems to be keyword based, so anything in the lexical field of ‘cybersecurity’ triggers the guardrails.” The result, researchers argue, is a model that is not merely safe but actively unusable for a large class of legitimate technical work. That tension — between blocking misuse and enabling productive use — is not new in AI, but Fable 5’s implementation has sharpened it to a point that the research community is no longer willing to accept quietly.
The biology block has produced its own absurdities. The Verge reported that Fable 5 refuses to answer questions a high-school biology student would be expected to handle — asking about cell division, for example, triggered the safety classifier. Developers attempting to use the model for legitimate scientific research have found themselves similarly walled off.

The IPO calculus
All of this is unfolding against an extraordinary financial backdrop. Anthropic confidentially filed for an IPO on 1 June at a valuation of roughly $965 billion — a figure that would have sounded absurd eighteen months ago but now sits in a bracket with OpenAI’s $852 billion pre-money filing and SpaceX’s expected public debut. Semafor reported that OpenAI filed confidentially one week after Anthropic, setting up a direct comparison for public-market investors who, as CNBC noted this week, are still getting a crash course in the token economy.
For Anthropic, the Fable 5 launch is both a product milestone and a narrative play. The company has consistently positioned safety as its differentiator — the reason enterprises and governments should trust it over a more permissive rival. Dario Amodei, Anthropic’s CEO, has made the argument in congressional testimony, in op-eds, and now, implicitly, in the product itself: a model that refuses dangerous requests is a model you can deploy broadly without losing sleep.
From an IPO-markets perspective, the bet is that institutional investors — pension funds, sovereign wealth funds, the allocators who will anchor a $965 billion offering — are more frightened by an unconstrained model than by one that occasionally refuses a code review. Whether that bet pays off depends on two things: whether the enterprise customers who actually pay the bills share that preference, and whether the public markets can absorb three AI mega-IPOs in a single quarter without one of them breaking the others.
What the competition reveals
OpenAI has taken a visibly different path. While the company has its own safety protocols — and its own controversies over them — its publicly available models have not drawn the same wholesale blocking of entire knowledge domains. The contrast is now legible enough to function as a competitive signal: Anthropic is the safety company, OpenAI is the capability company. Both are racing to public markets. Both are asking investors to value them on promises of future revenue that their current product economics cannot yet support.
The third entrant, SpaceX, operates in a different regulatory universe but competes for the same pool of mega-cap growth capital. The three-way squeeze — three companies, each seeking tens of billions in public float within weeks of one another — has no precedent in modern markets. Wall Street analysts are already privately fretting about absorption capacity.
The tension that won’t resolve
The backlash to Fable 5’s guardrails exposes a structural tension that the AI industry has been papering over with white papers and voluntary commitments: safer models are, by definition, less capable models. Every query Fable 5 refuses is a query that OpenAI’s next model might answer. Every researcher who finds the guardrails unusable is a potential customer who defects.
Anthropic’s 30-day data retention policy — introduced alongside Fable 5 — has already prompted Microsoft to restrict employee usage of the model, a signal that even enterprise customers with deep safety requirements are not willing to trade unlimited utility for absolute caution.
What happens next depends on whether Anthropic treats the researcher backlash as noise or as signal. The company could tune its classifiers to distinguish between offensive cybersecurity and defensive code review — a harder engineering problem than keyword-blocking, but one that would address the most vocal complaints. Or it could hold the line, betting that the IPO narrative of safety-first leadership outweighs the grumbling from a technically sophisticated but commercially marginal user base.
Either way, Fable 5 marks the moment when AI safety stopped being a philosophical debate and became a product decision with a price tag — and a very large number of zeroes attached to the upcoming S-1.
Sloane Carrington
Markets columnist. Analytical pieces and deep-dives on monetary policy, capital flows and corporate strategy. Reports from New York.


